RecruitingNCT05698745

Immunological Characteristics of Preclinical IBD

Prospective Study of the Natural History, Immunological and Genetic Characteristics of Preclinical Inflammatory Bowel Disease

Sponsor

Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

Enrollment

450 participants

Start Date

Jun 1, 2024

Study Type

OBSERVATIONAL

Conditions

Crohn Disease Ulcerative Colitis IBD

Summary

The purpose of this study is to evaluate disease progression, in terms of development of symptomatic disease and complications associated with IBD (e.g. fistula, abscess, stricture).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines the immune system characteristics of people in the very early (often symptom-free) stages of inflammatory bowel disease (IBD) — conditions like Crohn's disease or ulcerative colitis — to better understand how the disease starts before symptoms appear. **You may be eligible if...** - You are 18 or older - You were recently diagnosed with IBD — either incidentally during a colonoscopy (with no prior symptoms), or within 3 months of symptom onset - Your diagnosis meets recognized medical criteria for IBD **You may NOT be eligible if...** - You have already been receiving IBD treatment - You have another significant inflammatory or immune condition that could confound the results - You declined participation or cannot provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREbioespecimen samples

Blood, serum, plasma, urine, stools, small/large bowel tissue.

Locations(25)

Hospital Clínico Universitario de Santiago

Santiago de Compostela, A Coruña, Spain

Hospital Universitario Germans Trias i Pujol

Badalona, Barcelona, Spain

Althaia, Xarxa Assistencial Universitària de Manresa

Manresa, Barcelona, Spain

Hospital Universitari Mútua de Terrassa

Terrassa, Barcelona, Spain

Hospital Universitario Donostia

Donostia / San Sebastian, Gipuzkoa, Spain

Hospital Álvaro Cunqueiro (Complejo Hospitalario Universitario de Vigo)

Vigo, Pontevedra, Spain

Hospital Universitario de Cabueñes

Gijón, Principality of Asturias, Spain

Hospital Universitario Central de Asturias

Oviedo, Principality of Asturias, Spain

Hospital Universitario de Canarias

San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain

Hospital Universitario de Galdakao

Galdakao, Vizcaya, Spain

Hospital General Universitario Dr. Balmis

Alicante, Spain

Hospital de Sant Joan Despí Moisès Broggi

Barcelona, Spain

Hospital Universitario de Basurto

Bilbao, Spain

Hospital Universitario de Burgos

Burgos, Spain

Hospital Universitario Reina Sofía

Córdoba, Spain

Hospital Universitario de la Princesa

Madrid, Spain

Hospital General Universitario Gregorio Marañón

Madrid, Spain

Hospital Universitario Ramon y Cajal

Madrid, Spain

Hospital Universitario La Paz

Madrid, Spain

Complejo Hospitalario Universitario de Ourense

Ourense, Spain

Hospital Universitario Clínico de Valencia

Valencia, Spain

Hospital Univeristario y Politécnico La Fe

Valencia, Spain

Hospital Universitario Río Hortega

Valladolid, Spain

Hospital Clínico Universitario Lozano Blesa

Zaragoza, Spain

Hospital Universitario Miguel Servet

Zaragoza, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05698745

Related Trials

A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

NCT0696411319 locations

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

NCT0718500920 locations

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT0544256798 locations

Standardized Microbiota Transplant Therapy in Crohn's Disease

NCT066315862 locations

A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease

NCT062212544 locations